Target Audience:

This activity was developed for primary care physicians and health care professionals in the primary care field who manage patients with HCV and wish to improve standard practice care.

Educational Objectives:

Upon completion of this activity, participants should be able to:

• Identify patients who should receive HCV screening
• Recognize reasons for patient loss to follow-up
• Propose ways in which to improve patient retention
• Discuss the association of HCV with injected drug use
• List the barriers to HCV treatment
• Review ways to improve access to care
• Describe the importance of providing healthcare services to patients who inject drugs
• Compare the efficacy and safety of treatment regimens
• Demonstrate how to initiate appropriate evidence-based treatments
• Discuss any additional updates in the field of HCV and PWID

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF) have no relationships to disclose.

Learner Assurance Statement:

The Annenberg Center for Health Sciences at Eisenhower is committed to mitigating all conflict of interest issues that could arise as a result of individuals who control activity content and who have relationships with ACCME-defined ineligible companies. The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

This program is supported by an educational grant from AbbVie Pharmaceuticals.

Accredited by

Provided by